Abstract:<p>An estimated 466 million people suffer from hearing loss worldwide. Sensorineural hearing loss is characterized by degeneration of key structures of the sensory pathway in the cochlea such as the sensory hair cells, the primary auditory neurons and their synaptic connection to the hair cells – the ribbon synapse. Various strategies to protect or regenerate these sensory cells and structures are the subject of intensive research. Yet despite recent advances in our understandings of the capacity of the cochlea for repair and regeneration there are currently no pharmacological or biological interventions for hearing loss. Current research focusses on localized cochlear drug, gene and cell-based therapies. One of the more promising drug-based therapies is based on neurotrophic factors for the repair of the ribbon synapse after noise exposure, as well as preventing loss of primary auditory neurons and regrowth of the auditory neuron fibers after severe hearing loss. Drug therapy delivery technologies are being employed to address the specific needs of neurotrophin and other therapies for hearing loss that include the need for high doses, long-term delivery, localised or cell-specific targeting and techniques for their safe and efficacious delivery to the cochlea. Novel biomaterials are enabling high payloads of drugs to be administered to the cochlea with subsequent slow-release properties that are proving to be beneficial for treating hearing loss. In parallel, new gene therapy technologies are addressing the need for cell specificity and high efficacy for the treatment of both genetic and acquired hearing loss with promising reports of hearing recovery. Some biomaterials and cell therapies are being used in conjunction with the cochlear implant ensuring therapeutic benefit to the primary neurons during electrical stimulation. This review will introduce the auditory system, hearing loss and the potential for repair and regeneration in the cochlea. Drug delivery to the cochlea will then be reviewed, with a focus on new biomaterials, gene therapy technologies, cell therapy and the use of the cochlear implant as a vehicle for drug delivery. With the current pre-clinical research effort into therapies for hearing loss, including clinical trials for gene therapy, the future for the treatment for hearing loss is looking bright.</p>

Nanoparticle-based inner ear delivery systems for the treatment of hearing loss

Application of Nanomedicine in Inner Ear Diseases

Recent Advances and Future Research Directions for Hearing Loss Treatment Based on Nanoparticles

Inner Ear Drug Delivery for Sensorineural Hearing Loss: Current Challenges and Opportunities

New molecular therapies for the treatment of hearing loss

Exploring delivery systems for targeted nanotechnology-based gene therapy in the inner ear

Enhancement of Bioavailability and Bioequivalence of Drug Delivery in Sensory Neural Hearing Loss

Treating Sensorineural Hearing Loss: Recent Advances in Inner Ear Drug Delivery

Drug delivery systems for the treatment of sensorineural hearing loss

Polymer‐Based Nanoparticles for Inner Ear Targeted Trans Differentiation Gene Therapy.

Nanomaterials for Inner Ear Diseases: Challenges, Limitations and Opportunities

Biomaterials for non-invasive trans-tympanic drug delivery: requirements, recent advances and perspectives

Extracellular vesicles for developing targeted hearing loss therapy

A prestin-targeting peptide-guided drug delivery system rearranging concentration gradient in the inner ear: an improved strategy against hearing loss

Development of Magnetic Nanosystems with Potential for the Treatment of Inner Ear Pathologies

A state-of-the-art analysis of pharmacological delivery and artificial intelligence techniques for inner ear disease treatment

A forskolin-loaded nanodelivery system prevents noise-induced hearing loss

Programmable NIR Responsive Nanocomposite Enables Noninvasive Intratympanic Delivery of Dexamethasone to Reverse Cisplatin Induced Hearing Loss.

Magnetic/Acoustic Dual-Controlled Microrobot Overcoming Oto-Biological Barrier for On-Demand Multidrug Delivery against Hearing Loss

Mastoid approach for local drug delivery to the inner ear for treating hearing loss

Application of New Materials in Auditory Disease Treatment